Alamar Biosciences, Inc. Common Stock (ALMR) Stock
NYSE · ALMR
35.05
Fundamentals
Market cap
$2.42B
Price / Earnings ratio
-81.1x
Price / Sales ratio
32.6x
Price / Book ratio
7.7x
Return on assets
N/A
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Alamar Biosciences, Inc. Common Stock
Alamar Biosciences is a commercial-stage proteomics company on a mission to power precision proteomics to enable the earliest detection of disease. The company is establishing a gold standard in protein detection and analysis through its proprietary NULISA technology, purpose-built to address the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation.
SectorHealthcare
IndustryMedical Devices
Employees286
CEODr. Yuling Luo Ph.D.
IPO DateApr 17, 2026
HeadquartersFremont, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Yuling Luo Ph.D. | Co-Founder, Chairman & CEO | 1964 |
| Dr. Shiping Chen Ph.D. | Co-Founder, COO & Director | 1963 |
| Mr. Justin J. McAnear | Chief Financial Officer | 1976 |
| Mr. Timothy Ogden White J.D. | President | 1968 |
| Ms. Yiyuan Yin Ph.D. | Founder, VP of Technology & Acting Secretary | — |
| Dr. Xiao-Jun Ma Ph.D. | Chief Technology Officer | — |
| Dr. Stephen A. Williams M.D., Ph.D. | Chief Scientific Officer | 1960 |
| Ms. Carrie Mendivil | Vice President of Investor Relations & Corporate Communications | — |
| Mr. Alex Forrest-Hay | Senior Vice President of Sales | — |
| Ms. Anna Berdine | Senior Vice President of Marketing | — |
Fundamentals
Valuation
Market cap$2.42B
Price-to-sales ratio32.59
Price-to-book value7.73
Price-earnings ratio-81.10
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.58
Income Statement
Average volume401,438
EBITDA$-22.95M
1 year high (52w)$38.54
1 year low (52w)$18.85
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



